Omaxe Ltd
Omaxe ltd. is in the business of developing real estate properties for residential, commercial and retail purposes with a presence across 27 cities in 8 states of India. It has undertaken various projects in the areas of contractual construction, township development, building of commercial complexes, multi-storied apartments, etc.
[1] [2]
- Market Cap ₹ 1,460 Cr.
- Current Price ₹ 79.8
- High / Low ₹ 114 / 62.5
- Stock P/E
- Book Value ₹ -30.4
- Dividend Yield 0.00 %
- ROCE -61.4 %
- ROE -506 %
- Face Value ₹ 10.0
Pros
- Debtor days have improved from 112 to 72.5 days.
Cons
- Company has low interest coverage ratio.
- Company has a low return on equity of -76.3% over last 3 years.
- Contingent liabilities of Rs.2,723 Cr.
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Consumer Discretionary Realty Realty Residential, Commercial Projects
Quarterly Results
Consolidated Figures in Rs. Crores / View Standalone
Profit & Loss
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1,605 | 1,414 | 1,386 | 1,627 | 1,839 | 1,167 | 1,121 | 476 | 618 | 773 | 1,614 | 1,561 | 1,433 | |
| 1,378 | 1,180 | 1,144 | 1,343 | 1,579 | 1,038 | 924 | 594 | 665 | 1,077 | 1,958 | 2,169 | 2,005 | |
| Operating Profit | 226 | 234 | 242 | 284 | 260 | 128 | 198 | -119 | -47 | -303 | -343 | -608 | -572 |
| OPM % | 14% | 17% | 17% | 17% | 14% | 11% | 18% | -25% | -8% | -39% | -21% | -39% | -40% |
| 30 | 34 | 54 | 59 | 59 | 34 | 28 | 39 | 20 | 25 | 21 | 76 | 65 | |
| Interest | 131 | 144 | 147 | 155 | 169 | 74 | 108 | 161 | 121 | 113 | 130 | 195 | 240 |
| Depreciation | 10 | 14 | 10 | 9 | 9 | 9 | 73 | 63 | 47 | 65 | 54 | 37 | 38 |
| Profit before tax | 116 | 110 | 139 | 179 | 141 | 79 | 44 | -305 | -194 | -457 | -507 | -764 | -784 |
| Tax % | 32% | 46% | 45% | 41% | 39% | 38% | 319% | -23% | -17% | -23% | -20% | -10% | |
| 79 | 60 | 77 | 105 | 85 | 49 | -97 | -235 | -162 | -351 | -406 | -685 | -651 | |
| EPS in Rs | 4.29 | 3.28 | 4.20 | 5.58 | 4.59 | 2.68 | -5.32 | -12.86 | -8.72 | -19.02 | -22.01 | -37.51 | -35.61 |
| Dividend Payout % | 12% | 15% | 17% | 13% | 15% | 26% | 0% | 0% | 0% | 0% | 0% | 0% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 1% |
| 5 Years: | 7% |
| 3 Years: | 36% |
| TTM: | -23% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| TTM: | -9% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | -5% |
| 5 Years: | 0% |
| 3 Years: | 4% |
| 1 Year: | -25% |
| Return on Equity | |
|---|---|
| 10 Years: | -11% |
| 5 Years: | -39% |
| 3 Years: | -76% |
| Last Year: | -506% |
Balance Sheet
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 183 | 183 | 183 | 183 | 183 | 183 | 183 | 183 | 183 | 183 | 183 | 183 | 183 |
| Reserves | 1,746 | 1,794 | 1,848 | 1,936 | 2,014 | 1,558 | 1,456 | 1,222 | 1,062 | 715 | 298 | -388 | -740 |
| 1,299 | 1,346 | 1,328 | 1,503 | 1,802 | 1,856 | 1,672 | 1,530 | 1,128 | 1,107 | 796 | 796 | 1,419 | |
| 3,225 | 3,585 | 4,353 | 4,704 | 4,129 | 7,163 | 7,239 | 8,108 | 9,545 | 11,555 | 12,546 | 14,300 | 14,866 | |
| Total Liabilities | 6,453 | 6,908 | 7,712 | 8,326 | 8,128 | 10,760 | 10,549 | 11,042 | 11,918 | 13,560 | 13,822 | 14,891 | 15,728 |
| 131 | 118 | 600 | 604 | 604 | 599 | 747 | 671 | 627 | 582 | 565 | 606 | 595 | |
| CWIP | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments | 16 | 20 | 22 | 12 | 12 | 12 | 12 | 12 | 13 | 14 | 29 | 21 | 20 |
| 6,306 | 6,769 | 7,091 | 7,710 | 7,512 | 10,149 | 9,789 | 10,359 | 11,278 | 12,964 | 13,228 | 14,264 | 15,112 | |
| Total Assets | 6,453 | 6,908 | 7,712 | 8,326 | 8,128 | 10,760 | 10,549 | 11,042 | 11,918 | 13,560 | 13,822 | 14,891 | 15,728 |
Cash Flows
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 139 | 362 | 91 | 121 | 19 | 400 | 638 | 566 | 783 | 469 | 987 | 1,007 | |
| 11 | -6 | 6 | 20 | 21 | 16 | 106 | 23 | -22 | -142 | -64 | -126 | |
| -152 | -391 | -105 | -173 | -35 | -435 | -783 | -517 | -740 | -262 | -924 | -770 | |
| Net Cash Flow | -2 | -34 | -7 | -32 | 4 | -18 | -39 | 72 | 21 | 65 | -1 | 111 |
Ratios
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 197 | 199 | 208 | 235 | 158 | 110 | 111 | 298 | 227 | 182 | 81 | 73 |
| Inventory Days | 16,214 | |||||||||||
| Days Payable | 1,755 | |||||||||||
| Cash Conversion Cycle | 197 | 199 | 208 | 235 | 158 | 110 | 111 | 298 | 227 | 182 | 14,539 | 73 |
| Working Capital Days | 470 | 601 | 570 | 547 | 461 | 532 | 508 | 911 | 424 | 156 | -62 | -333 |
| ROCE % | 8% | 8% | 9% | 10% | 8% | 4% | 5% | -5% | -3% | -16% | -23% | -61% |
Documents
Announcements
-
Announcement under Regulation 30 (LODR)-Newspaper Publication
2d - Copies of newspaper publication w.r.t. Special Window for Re-lodgement of transfer request of physical shares and communication on other matters.
- Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011 2d
-
Intimation With Respect To Project Launch And Regulatory Approval
24 Dec - RERA registration for Omaxe Eternity-2 Phase 17, Reg. UPRERAPRJ141620/12/2025; launch 26-12-2025; valid till 07-05-2030.
-
Closure of Trading Window
24 Dec - Trading window closed from Jan 1, 2026 until 48 hours after Q3/9M results for Dec 31, 2025.
-
Announcement Under Regulation 30 Of SEBI LODR Regulation 2015
24 Dec - Letter to BSE on Dec 24, 2025: no undisclosed information affecting price/volume.
Annual reports
-
Financial Year 2025
from bse
-
Financial Year 2024
from bse
-
Financial Year 2023
from bse
-
Financial Year 2022
from bse
-
Financial Year 2021
from bse
-
Financial Year 2020
from bse
-
Financial Year 2019
from bse
-
Financial Year 2018
from bse
-
Financial Year 2017
from bse
-
Financial Year 2016
from bse
-
Financial Year 2015
from bse
-
Financial Year 2014
from bse
-
Financial Year 2013
from nse
-
Financial Year 2013
from bse
-
Financial Year 2012
from nse
Concalls
-
Jul 2020TranscriptAI SummaryPPT
-
May 2018TranscriptAI SummaryPPT
-
Feb 2018TranscriptAI SummaryPPT
-
Nov 2017TranscriptAI SummaryPPT
-
Aug 2017TranscriptAI SummaryPPT
-
Jun 2017TranscriptAI SummaryPPT
-
Feb 2017TranscriptAI SummaryPPT
-
Dec 2016TranscriptAI SummaryPPT
-
May 2016Transcript PPT
-
Feb 2016TranscriptPPT
-
Nov 2015TranscriptAI SummaryPPT
-
Aug 2015TranscriptAI SummaryPPT
Project Portfolio and Execution
The Co.’s product portfolio consists of residential projects, integrated and hi-tech townships, office and commercial projects including malls, and others. It also provides construction contracting services. At the end of FY 2022-23, since inception, Omaxe had approximately delivered 132 Mn. Sq. Ft. (12.26 Mn. Sq. Mtr.) of developed areas across various project categories. During FY22, it delivered 2.75 million square feet. These deliveries encompassed projects located in various cities such as Chandigarh, Lucknow, Faridabad, Ludhiana, and Vrindavan.[1]